NCT04965766
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04965766
Title Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer (ICARUS BREAST)
Acronym ICARUS BREAST
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gustave Roussy, Cancer Campus, Grand Paris
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Centre Georges François Leclerc ACTIVE_NOT_RECRUITING Dijon 21079 France Details
CHU de Limoges RECRUITING Limoges 87042 France Details
Centre Léon Bérard RECRUITING Lyon 69373 France Details
Institut Paoli Calmettes RECRUITING Marseille 13273 France Details
Institut Régional du Cancer de Montpellier RECRUITING Montpellier 34298 France Details
Centre Antoine Lacassagne RECRUITING Nice 06189 France Details
Institut Curie RECRUITING Paris 75005 France Details
Hôpital Tenon RECRUITING Paris 75020 France Details
Institut de Cancérologie de l'Ouest RECRUITING Saint-Herblain 44805 France Details
Institut Claudius Regaud RECRUITING Toulouse 31059 France Details
Gustave Roussy RECRUITING Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field